Back to the main directory
Press Release
- General Cannabis Corp. Announces Board Changes by GlobeNewsWire
- Suncor Energy to release second quarter 2020 financial results by GlobeNewsWire
- Mohawk Industries, Inc. le invita a participar en la teleconferencia web del segundo trimestre de 2020 by GlobeNewsWire
- Mohawk Industries, Inc. ti invita a partecipare alla teleconferenza Web sul secondo trimestre 2020 by GlobeNewsWire
- Mohawk Industries, Inc. nodigt u uit om deel te nemen aan de online conference call over het tweede kwartaal van 2020 by GlobeNewsWire
- Mohawk Industries, Inc. 邀請您åƒåŠ 2020 年第二å£åº¦ç¶²çµ¡é›»è©±æœƒè° by GlobeNewsWire
- Kelt Announces Extension of Credit Facility Re-Determination by Newsfile Corp.
- Novra Announces First Quarter 2020 Financial Results by Newsfile Corp.
- ILA Announces Results for Q1 2020 Ended March 31, 2020 by GlobeNewsWire
- NexOptic Provides Notice of Acceleration of Expiry Date of Re-Priced Warrants by GlobeNewsWire
- TC Energy to issue second quarter results July 30 by GlobeNewsWire
- Ovid Therapeutics et Angelini Pharma concluent un accord de licence exclusif concernant le développement, la fabrication et la commercialisation d'OV101 pour le traitement du syndrome d'Angelman en Europe by GlobeNewsWire
- Ovid Therapeutics, ìœ ëŸ½ ë‚´ ì—”ì ¤ë§Œì¦í›„êµ° 치료용 OV101ì˜ ê°œë°œ, ìƒì‚°, ìƒìš©í™” 위해 Angelini Pharma와 ë…ì ë¼ì´ì„ 스 계약 ì²´ê²° by GlobeNewsWire
- A Ovid Therapeutics e a Angelini Pharma celebram um acordo de licença exclusivo para desenvolver, fabricar e comercializar o medicamento OV101 para o tratamento da sÃndrome de Angelman na Europa by GlobeNewsWire
- Ovid Therapeutics 與 Angelini Pharma 簽訂ç¨å®¶è¨±å¯å”è°ä»¥é–‹ç™¼ã€ç”Ÿç”¢å’Œå•†æ¥åŒ– OV101，以治療æ洲的天使綜åˆç—‡ by GlobeNewsWire
- Scorpio Tankers Inc. Announces Purchase of Common Shares by Scorpio Services Holding Limited and Call Options by President of the Company by GlobeNewsWire
- Royal Financial, Inc. Announces Preliminary Fiscal Year 2020 Fourth Quarter and Year End Earnings Results by GlobeNewsWire
- Mowi ASA (OSE:MOWI): Q2 2020 Trading update by GlobeNewsWire
- ObsEva SA Awarded Clinical Science Award for Oral Presentation at ESHRE Virtual 36th Annual Meeting, July 2020 by GlobeNewsWire
- ASML reports €3.3 billion net sales at 48.2% gross margin in Q2 2020 by GlobeNewsWire
- LHV 14. juuli investorseminari salvestus by GlobeNewsWire
- Sbanken ASA: Tar markedsandeler innen boliglån og fondssparing by GlobeNewsWire
- À la suite du succès de l'augmentation de capital de plus de 7,3 millions d’euros, Pixium Vision annonce la répartition finale du capital et le renforcement de deux investisseurs historiques by GlobeNewsWire
- SEB:s resultat för andra kvartalet 2020 by GlobeNewsWire
- DGAP-News: U.S. LICENSE AGREEMENT FOR BYFAVOTM (REMIMAZOLAM) BETWEEN PAION AND COSMO ASSIGNED FROM COSMO TO ACACIA by EQS Group AG
- MIC to Host Conference Call / Webcast and Discussion of Second Quarter 2020 Financial Results Tuesday, August 4, 2020 by BusinessWire
- Suncor Énergie publiera les résultats financiers du deuxième trimestre de 2020 by GlobeNewsWire
- Mohawk Industries, Inc. stellt in einer Webkonferenz seine Ergebnisse für Q2/2020 vor by GlobeNewsWire
- Mohawk Industries, Inc. vous invite à vous joindre à la conférence téléphonique du deuxième trimestre 2020 diffusée sur le Web by GlobeNewsWire
- Mohawk Industries, Inc. приглашает Ð²Ð°Ñ Ð¿Ñ€Ð¸ÑоединитьÑÑ Ðº веб-конференции по итогам второго квартала 2020 года by GlobeNewsWire
- Mohawk Industries, Inc.邀请您å‚与2020年第二å£åº¦ç½‘络电è¯ä¼šè®® by GlobeNewsWire
- BlueLinx to Host Second Quarter 2020 Financial Results Conference Call and Webcast by GlobeNewsWire
- Keytronic Selected as a Top 10 Contract Manufacturing Service Provider for 2020 by GlobeNewsWire
- Sunnova Announces Second Quarter 2020 Earnings Release Date and Conference Call by BusinessWire
- Ovid Therapeutics und Angelini Pharma schließen exklusive Lizenzvereinbarung zur Entwicklung, Herstellung und Vermarktung von OV101 zur Behandlung des Angelman-Syndroms in Europa ab by GlobeNewsWire
- Ovid Therapeutics y Angelini Pharma firman un acuerdo exclusivo de licencia para desarrollar, fabricar y comercializar OV101 para el tratamiento del sÃndrome de Angelman en Europa by GlobeNewsWire
- オービッド･セラピューティクスã¨ã‚¢ãƒ³ã‚¸ã‚§ãƒªãƒ¼ãƒ‹ï½¥ãƒ•ã‚¡ãƒ¼ãƒžã€ã‚¢ãƒ³ã‚¸ã‚§ãƒ«ãƒžãƒ³ç—‡å€™ç¾¤ã®æ²»ç™‚è–¬ã¨ã—ã¦ã®OV101ã®ãƒ¨ãƒ¼ãƒãƒƒãƒ‘ã«ãŠã‘る開発ã€è£½é€ ã€å•†å“化ã«é–¢ã™ã‚‹ç‹¬å ãƒ©ã‚¤ã‚»ãƒ³ã‚¹å¥‘ç´„ã‚’ç· çµ by GlobeNewsWire
- Ovid Therapeutics dan Angelini Pharma Menandatangani Perjanjian Lesen Eksklusif untuk Membangunkan, Membuat dan Memperdagangkan OV101 bagi Rawatan Sindrom Angelman di Eropah by GlobeNewsWire
- Ovid Therapeuticså’ŒAngelini Pharmaç¾è®¢å¼€å‘ã€ç”Ÿäº§å’Œå•†ä¸šåŒ–独家许å¯å议以利用OV101在欧洲治疗天使综åˆå¾ by GlobeNewsWire
- CTO Realty Growth Announces 3 Land Sale Transactions by Land JV, Including $40.9 Million Transaction to Affiliates of SITEX Properties USA by GlobeNewsWire
- Immutep Announces United States Patent Grant for IMP701 Antibody by GlobeNewsWire
- PyroGenesis Announces Q1 2020 Results: Revenues of $736K, Gross Margin of 37%, Current Backlog $30MM, Provides Q2 2020 and Year End Guidance by GlobeNewsWire
- Marquage CE du panel respiratoire BIOFIRE® 2.1 plus incluant le SARS-CoV-2 by BusinessWire
- Acacia Pharma Assigned US License for BYFAVOâ„¢ (remimazolam) by Cosmo Pharmaceuticals NV by GlobeNewsWire
- Recording of LHV Group's 14 July investor webinar by GlobeNewsWire
- Sbanken ASA: Gaining market shares in mortgages and savings by GlobeNewsWire
- Pixium Vision announces final share capital breakdown and strengthening of two historical investors following successful completion of capital increase over €7.3 million by GlobeNewsWire
- SEB's second quarter 2020 result by GlobeNewsWire
- DGAP-News: Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Enrollment of First Patient in VIVIAD, European Phase 2b Alzheimer's Disease Study with Varoglutamstat (PQ912) by EQS Group AG
- DGAP-News: Automotive-Sparte von paragon richtet sich nach Umsatzrekord in 2019 konsequent auf die Nach-Corona-Zeit aus by EQS Group AG